New data suggests the weight-loss drug Wegovy may significantly reduce the risk of heart disease even before users experience ...

Tirzepatide slashed weight by 20%, leading researchers to call this a new “golden age” for weight-loss therapies.

Tirzepatide (trade name Zepbound) promoted greater weight loss in individuals with obesity than did semaglutide (trade name Wegovy) in a clinical trial that compared the safety and efficacy of the ...

New study finds weight loss jabs not only help tackle obesity but may significantly reduce alcohol use, offering wide health ...

While the primary target for these medication is weight loss, it’s not the only metric by which the drugs should be evaluated ...

Mounjaro and Wegovy are two of the biggest names in the world of weight-loss drugs but it's been unclear which is more ...

Semaglutide can rapidly reduce heart attacks and other serious cardiovascular complications in adults with overweight or obesity who have pre-existing ...

Medications like semaglutide and liraglutide may help to reduce the risk for heart attacks, strokes, and other major adverse cardiovascular events ...

The head-to-head examination of these weight loss drugs provides doctors with 'robust' data on their effectiveness.

GLP-1s may help reduce alcohol intake among adults with overweight or obesity, according to data presented at the European ...

The obesity drug helped people trim about two inches more off their waists than Wegovy in the first head-to-head study of the ...

Sophia Umansky—the daughter of Kyle Richards and Mauricio Umansky—doubled down on her decision to take Mounjaro, despite ...